|
Mobile version
|
||||||||||||||||||||||||||||||||||||||||||||||||||
PARP inhibitor for triple-negative breast cancer Medscape Medical News Share     The investigational agent iniparib (Sanofi-Aventis) improved a number of clinical measures, including overall survival, in women with metastatic triple-negative breast cancer, according to final phase 2 study results. The results for iniparib, which inhibits PARP, or poly(adenosine-disposphate-ribose) polymerase, were presented earlier at the 2010 European Society for Medical Oncology Congress and have been published online in the New England Journal of Medicine. More
Medical laboratory technologists a U.S. News & World Report 'Best Career' for 2011 DARKDaily.com Share
Medical technologists and clinical laboratory scientists were declared among "The 50 Best Careers of 2011" by U.S. News & World Report in its annual survey of high-demand careers. Editors at the respected news magazine declared "clinical lab technicians and technologists" to be the "unsung heroes of the health care industry." More AIDS gel prevents infection in monkeys Reuters via MSNBC Share
An experimental gel protected female monkeys from the AIDS virus in a test designed to mimic human sexual transmission, researchers said. The gel uses an AIDS drug along with a zinc compound and protected all animals tested from infection with the monkey version of HIV, the researchers report in the Public Library of Science open-source journal PLoS ONE. More Hidden epidemic: Chronic HBV and HCV infections Clinical Laboratory News Share
A new report released by the American Association for the Study of Liver Diseases and the Trust for America's Health found that 2 million Americans are currently living with chronic hepatitis B virus (HBV) infection and 2.7–3.9 million more are infected with hepatitis C virus (HCV). Experts estimate that 65–75 percent of these individuals don't know they are infected. More Genetic abnormalities found in stem cell lines Los Angeles Times Share
People have pinned a lot of hopes on pluripotent stem cells — which, because of their amazing capacity to morph into other types of cells, have been touted as a potential source for replacement tissues that might someday help reverse spinal cord injuries, Alzheimer's disease, and even the damage caused by heart attacks. More
Sentinel node biopsy not useful for many with cutaneous melanoma Reuters Health via Medscape Share
Sentinel lymph node biopsy (SLNB) is variably useful for melanoma patients with localized disease and clinically negative nodes if they have tumors of intermediate thickness, but is not useful for those with thin or thick tumors, according to a new analysis of published research. Dr. Arthur R. Rhodes of Rush University in Chicago found no survival benefit for lymphatic mapping with SLNB, with therapeutic lymph node dissection (TLND) for positive nodes. More Promise shown in simple blood test for Alzheimer's disease AOL Health Share
A simple blood test for Alzheimer's disease made by a company in Miami is being hailed as a groundbreaking new way of detecting the frightening memory-loss illness. Researchers around the world characterized the findings as "exciting," "promising" and "fresh." More Scientists trace root of male hair loss to faulty stem cells AOL Health Share
Men of all ages are anxiety-ridden at the idea of losing their hair. But considering how many fret about male pattern baldness and how many experience it, surprisingly little has been understood about its causes. New research in the Journal of Clinical Investigation has found that stem cells are involved in what happens to the scalp to trigger hair loss. More Study shows where MRSA colonizes on the human body Infection Control Today Share
When methicillin-resistant S. aureus (MRSA) is carried in the nose (nares), it is a risk factor for an invasive infection, including a surgical site infection. Some studies have found that the heavier the carriage of MRSA in the nose, the greater the risk of transmission to others and the greater risk of infection to the patient. Few studies to date have assessed the differences in quantity of MRSA at different body sites. A new study from Rhode Island Hospital now sheds light on both the quantity of MRSA at different body sites and the relationship between the quantities at different sites. The study is published in the Journal of Clinical Microbiology. More |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||
